News

Scientists at the University of British Columbia and BetaLogics, have shown for the first time that Type 2 diabetes can be effectively treated with a combination of specially-cultured stem cells and conventional diabetes drugs.

Facility is designed for CAR T cells and other cancer immunotherapies.

Sox9 appears to lead the activation of super-enhancers that boost genes associated with stem cell plasticity.

Kite to expand product pipeline in TCRs for the treatment of solid tumors, complementing Kite's Chimeric Antigen Receptor pipeline.

Researchers at the University of Georgia have discovered that manipulation of a specific gene in a hardwood tree species not only makes it easier to break down the wood into fuel, but also significantly increases tree growth.

Highly sensitive genomic analysis of acute lymphoblastic leukemia cells reveals for the first time how the malignant cells evolve to cause relapse.

NIOSH utilizes mass spectrometry imaging tools for workplace toxin inhalation studies.

Collaboration to evaluate the combination of varlilumab and MPDL3280A.

200L scale production leverages Emergent's unique expertise and capabilities in MVA-based vaccine product development and manufacturing.

International pharmaceutical development and manufacturing company will create 100 new jobs, capital investment of more than $9 million.